Artificial intelligence has become a mainstream topic of conversation, with industry, investors and the media discussing its possible impact on all areas of our personal and professional lives.
But up till now there’s been a missing component in healthcare’s AI conversation: the voices of patients themselves. For all the hype and the headlines, what do we actually know about how people with chronic conditions will react when presented with the prospect of their health being managed by algorithms instead of doctors, or by smartphones and sensors rather than nurses?
To develop what we believe to be the first window into patients’ thought processes as they begin to confront an AI future, Syneos Health Communications surveyed approximately 800 European and American patients in three disease areas – atrial fibrillation, Type 2 diabetes, breast cancer – and approximately 200 caregivers for people with Parkinson’s disease.
In this report, the survey results are coupled with additional insight from follow-up focus groups exploring current ideas, expectations and concerns about AI from these patients and caregivers.
